Delivery Order SPE2DB22D1106-SPE2DB25FFBP9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tenivac syringes (0.5mL) valued at $1,135.05 on July 29, 2025, with a completion date of July 30, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $18,881.66 to AmerisourceBergen Drug Corp for the supply of TENIVAC vials (0.5ML) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award, with performance to be executed from the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with...
- This is a $1,302.54 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4565305627 TENIVAC SYRINGE 0.5ML, a vaccine product. The order has an ultimate completion date of August 1, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,525.86 firm fixed-price delivery order is for the supply of TENIVAC SYRINGE 0.5ML, a medical product. The contract has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on July 30, 2025, for $10,525.72 to supply TYPHIM VI 25 MCG/0.5 ML vaccine syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and will be performed at the contractor's Conshohocken facility. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $423,000 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4561400481 TENIVAC syringes in 0.5mL quantities to the Defense Logistics Agency. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is July 3 through July 5, 2023. No subcontractors or set-aside designations were identified. The Defense Logistics...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,302.54 firm fixed-price delivery order is for TENIVAC SYRINGE 0.5ML, a medical supply product. The contract has an ultimate completion date of July 1, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December...
- This is a $1,745.36 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide TENIVAC VIAL 0.5ML medical supplies. The contract has an ultimate completion date of June 24, 2025 and is not set aside. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a wide range of pharmaceutical products and medical supplies in...
- The Defense Logistics Agency awarded a $2,114.60 delivery order to Amerisourcebergen Drug Corporation for 4562193481 TENIVAC SYRINGE 0.5ML under a firm fixed price contract. The order is for medical supplies to be delivered to a facility in Conshohocken, Pennsylvania between September 15-18, 2023. Amerisourcebergen will serve as the prime contractor, with performance taking place at its Corporate Office Division location. No subcontractors or set aside designations were indicated. The Defense...
- The Defense Logistics Agency awarded a $13,636.23 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Capvaxive 0.5 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 25, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBP9Delivery Order
The Defense Logistics Agency awarded a $1,135.05 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for TENIVAC syringes in 0.5ML quantities, with performance completion scheduled for August 6, 2025. This non-set-aside contract represents a routine medical supply procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 pharmaceutical support vehicle valued through December 2026. The delivery location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's critical role as a federal pharmaceutical distributor supporting military and veteran healthcare systems. As a major healthcare solutions provider, the company leverages its prime IDC to fulfill ongoing federal medical supply requirements across multiple therapeutic domains, including vaccines, medications, and specialized medical devices. The firm fixed pricing structure and rapid turnaround on this syringe order demonstrates the efficiency of the DLA's standing contract vehicle, which enables expedited procurement of essential medical commodities for Defense Health Agency operations and other government healthcare beneficiaries worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/5/25 |